KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Other Non Operating Income: 2010-2025

Historic Other Non Operating Income for Nektar Therapeutics (NKTR) over the last 16 years, with Sep 2025 value amounting to -$121,000.

  • Nektar Therapeutics' Other Non Operating Income fell 0.83% to -$121,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $270,000, marking a year-over-year increase of 104.09%. This contributed to the annual value of -$390,000 for FY2024, which is 93.76% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Other Non Operating Income of -$121,000 as of Q3 2025, which was down 146.54% from $260,000 recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Other Non Operating Income registered a high of $33.4 million during Q1 2022, and its lowest value of -$6.3 million during Q4 2023.
  • Over the past 3 years, Nektar Therapeutics' median Other Non Operating Income value was -$120,000 (recorded in 2024), while the average stood at -$566,545.
  • In the last 5 years, Nektar Therapeutics' Other Non Operating Income tumbled by 214.36% in 2021 and then skyrocketed by 2,190.49% in 2022.
  • Over the past 5 years, Nektar Therapeutics' Other Non Operating Income (Quarterly) stood at -$383,000 in 2021, then skyrocketed by 161.60% to $2.0 million in 2022, then slumped by 116.34% to -$6.3 million in 2023, then surged by 97.87% to -$135,000 in 2024, then dropped by 0.83% to -$121,000 in 2025.
  • Its last three reported values are -$121,000 in Q3 2025, $260,000 for Q2 2025, and $266,000 during Q1 2025.